Healthcare regulation

CMS prior authorization rule finally crosses the finish line

CMS recently finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F). Review some of the key changes CMS made to their original proposal, how changes impact requirements for payers and providers, and how Redox can help them reach compliance.

Breaking down the CMS proposed prior authorization rules

The healthcare industry is continues to evolve, recent proposals from CMS are aimed at reducing the burden of prior authorization. As healthcare organizations work to stay compliant with the new rules, having expertise in the three leading data standards, FHIR, X12, and CDA, has become an absolute must. We take a closer look at why this expertise is crucial in ensuring compliance with the new CMS regulations.

HIPAA for healthcare products

In the bullpen HIPAA for Healthcare Products: Strategic fundamentals In this first of a trilogy on healthcare…

Revelations from DC: We’re all on the same side

This past week, I’ve been at America’s Health Insurance Plan’s (AHIP) National Conferences on Medicare and Medicaid in…

What is MACRA?

While our main focus is the creation and adoption of innovative technology solutions in healthcare, we would be…

What happened to Meaningful Use stage 3? Do we still…

Making sense of healthcare regulations is difficult. Just when you finally wrap your head around a major program,…

Is FDA approval the secret to digital health application success?

From day one, Redox has been passionate about supporting the “little guys”. So much of what we do…

Why disrupt healthcare?

In healthcare, about ⅓ of each dollar spent doesn’t improve health. That’s around $750 billion dollars of waste…

Stay in the know! Subscribe to our
newsletter..